Element Capital Management LLC Immuno Gen, Inc. Transaction History

Element Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 13, 2019	SELL	$3.94 - $9.7 $46,819 - $115,265	-11,883 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$8.6 - $11.26 $174,365 - $228,296	-20,275 Reduced 63.05%	11,883 $113,000
Q2 2018 Aug 14, 2018	BUY	$9.52 - $12.15 $142,200 - $181,484	14,937 Added 86.74%	32,158 $313,000
Q1 2018 May 15, 2018	BUY	$6.7 - $12.95 $115,380 - $223,011	17,221 New	17,221 $181,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Element Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Element Capital Management LLC with notifications on news.